Hypocomplementemia in multiple myeloma

Leukemia and Lymphoma

Volumn 33, Issue 3-4, 1999, Pages 365-370

  Lugassy, Gilles ^a   Platok, Irina ^a   Schlesinger, Menahem ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Complement system; Multiple myeloma

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; INFECTIOUS COMPLICATION; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0032890872     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058437     Document Type: Article

References (17)

1. Zulian GB., (1997) Multiple Myeloma: Clinical Evaluation of Plasma Cell Lymphoproliferative Disorders and Initial Management. Seminars in Hematology, 34:29-39.
2. Riccardi A., Gobbi PG., Ucci (1991). Changing clinical presentation of multiple myeloma. European Journal of Cancer. 27:1401-5.
3. Jacobson DR., Zolle-Pazner S., (1986). Immuno-suppression and infection in multiple myeloma. Seminars in Oncology, 2:282-292
4. Ross SC., Densen P., (1984). Complement deficiency states and infection. Medicine; 63 : 243-273
5. Durie BGM., Salmon SE., (1975). A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer; 36: 842
6. Mancini G., Carbonara A.D., Heremans J.F., (1965). Immunochemical quantification of antigens by single radial immunodiffusion. Immunochemistry, 2:235-254.
7. Pilarski L.M., Mant M.J., Ruetner B.A., et al. (1984). Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. Journal of Clinical Investigation; 74:1301-6
8. Barlogie B., Epstein J., Selsanayagam P., Alexanian R., (1989). Plasma cell myeloma - new biological insights and advances in therapy. Blood; 73:865-879
9. Schlesinger M., Broman I., Lugassy G., (1996). The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. Leukemia; 10:1509-13
10. Barlogie B., Gale RP., (1992). Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. American Journal of Medicine; 93:443-450
11. Jacobson DR,m Zolla-Pazner S., (1986). Immunosuppression and infection in Multiple Myeloma. Seminars in Oncology; 13:282-290.
12. Kraut EH., Sagore AL., (1981). Alternative pathway of complement in Multiple Myeloma. American Journal Hematology; 11 :335-345.
13. Zurlo JJ., Schechter GP., Fries L., (1989). Complement abnormalities in multiple myeloma. American Journal Medicine; 87:411-420.
14. Pascual M., Mack Pascual S., Schifferli J.A., (1997). Paraproteins and complement depletion: pathogenesis and clinical syndromes. Seminars in Hematology; 34:40-48
15. Lugassy G., Schlesinger M., (1995). The complement system in chronic lymphocytic leukemia: a possible role in autoimmune manifestations. Leukemia and Lymphoma; 18:179-184
16. Nikolova E.B., Tomana M., Russel M.W., (1994). All forms of humans IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen clone. Scandinavian Journal Immunology; 39:275-280
17. Lissoni, P., Barni S., Cattaneo G., et al. (1990) Activation of the complement system during immunotherapy of cancer with interleukin 2 - A possible explanation of the capillary leak syndrome. International Journal of Biological Markers; 5:195-7